期刊文献+

不同冻存方法对组织工程骨生物活性的影响

Effect of various cryopreservation methods on bioactivity of tissue engineered bone
下载PDF
导出
摘要 目的:了解不同冻存方法对组织工程骨生物活性的影响。方法:以骨髓基质干细胞(marrow stromal cells,MSCs)复合部分脱蛋白骨培养制备组织工程骨,实验分为A组:组织工程骨用添加冻存保护剂的保存液保存;B组:组织工程骨用不添加冻存保护剂的保存液保存;C组:组织工程骨未行低温保存;D组:单纯MSCs培养。A组和B组的组织工程骨于-196℃的液氮中冻存3个月,3个月后复温冻存的组织工程骨。用倒置相差显微镜和扫描电镜观察MSCs的粘附和分布情况、检测细胞活力和碱性磷酸酶(alkaline phosphatase,ALP)活性、流式细胞仪分析细胞周期。结果:MSCs在材料表面和孔隙内均可粘附和分布,粘附于材料的细胞活力大小依次为:C组>A组>B组(P<0.01,P<0.05),粘附于材料的细胞ALP活性大小依次为:C组>A组>B组(P<0.01)。各组细胞周期未见明显变化,未见异倍体细胞。结论:选择适宜的冻存保护剂对组织工程骨的生物活性有一定的保护作用。 Objective To study the effect of various cryopreservation methods on bioactivity of tissue engineered bone.Methods MSCs were cocultured with partialy deproteinized bone to produce tissue engineered bone.The experiment was divided into A,B,C and D group.Group A:Tissue engineered bone had been stored in preservation solution with cryopreservation medium.Group B:Tissue engineered bone had been stored in preservation solution without cryopreservation medium.Group C:Tissue engineered bone without cryopreservation.Group D:Simple MSCs were cultured.The tissue engineered bone of group A and B had been stored in liquid nitrogen at-196℃ for three months and thawed three months later.The cell-material complex was observed under phase microscope and electronic scanning microscope in order to evaluate the adhesion and distribution of MSCs,cell viability and ALP activity were measured,cell cycle was analysed by flow cytometer.Results MSCs adhered to the surface of material and distributed in the hole of material.The cell viability of MSCs adhered to material was C>A >B group(P<0.01,P<0.05).The ALP activity of MSCs adhered to material was C>A >B group(P<0.01).The cell cycle of different groups did not change significantly,the abnormal cells were not seen.Conclusion The choice of proper cryopreservation solution could optimize the bioactivity of tissue engineered bone.
出处 《中国美容医学》 CAS 2007年第2期147-150,共4页 Chinese Journal of Aesthetic Medicine
基金 全军医学科学技"术十一五"计划课题基金资助项目(编号:06MA081)
关键词 组织工程 骨髓基质干细胞 脱蛋白骨 生物活性 tissue engineering marrow stromal cells deproteinized bone bioactivity
  • 相关文献

参考文献12

  • 1方福德 周吕 丁濂.现代医学实验技巧全书[M].北京:北京医科大学中国协和医科大学联合出版社,2002.557-563.
  • 2[2]Brien FJ,Harley BA,Yannas IV,et al.Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds[J].Biomaterials,2004,25(6):1077-1086.
  • 3[3]Windrum P,Morris TC,Drake MB,et al.EBMT Chronic Leukaemia Working Party Complications Subcommittee.Variation in dimethyl sulfoxide use in stem cell transplantation:a survey of EBMT centres[J].Bone Marrow Transplant,2005,36(7):601-603.
  • 4[4]Kotobuki N,Hirose M,Machida H,et al.Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells[J].Tissue Eng,2005,11(5-6):663-673.
  • 5[5]Rust PA,Costas C,Cannon SR,et al.Characterisation of cryopreserved cells freshly isolated from human bone marrow[J].Cryo Letters,2006,27(1):17-28.
  • 6[6]Ji L,Pablo JJ,Palecek SP.Cryopreservation of adherent human embryonic stem cells[J].Biotechnol Bioeng,2004,88(3):299-312.
  • 7[7]Kofron MD,Opsitnick NC,Attawia MA,et al.Cryopreservation of tissue engineered constructs for bone[J].J Orthop Res,2003,21(6):1005-1010.
  • 8[8]Claase MB,Grijpma DW,Mendes SC,et al.Porous PEOT/PBT scaffolds for bone tissue engineering:preparation,characterization,and in vitro bone marrow cell culturing[J].J Biomed Mater Res,2003,64(2):291-300.
  • 9[9]Ebertz SL,McGann LE.Cryoprotectant permeability parameters for cells used in a bioengineered human corneal equivalent and applications for cryopreservation[J].Cryobiology,2004,49(2):169-180.
  • 10[10]Gole MD,Poulsen D,Marzo JM,et al.Chondrocyte viability in press-fit cryopreserved osteochondral allografts[J].J Orthop Res,2004,22 (4):781-787.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部